SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (5658)11/10/1998 11:55:00 AM
From: Henry Niman   of 6136
 
I missed the beginning, but David Molowa was just on CNBC. I think that he initially mentioned BGEN as a larger Biotech. When asked about a smaller ones, he gave LGND, with 2 drugs slated for approval by the end of the year, and a launch and profitability next year. For acquisitions he mentioned SEQU and AGPH, and as far as stocks getting too pricey, he mentioned the BS downgrade of AMGN today, based on price.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News